MedPath

RCT Between UPP and Controls in Adult OSA

Not Applicable
Withdrawn
Conditions
Obstructive Sleep Apnea
Registration Number
NCT02522247
Lead Sponsor
Karolinska University Hospital
Brief Summary

To compare the effect of uvulopalatoplasty with no treatment in treating adult OSA.

Detailed Description

Two arms: the intervention group undergo uvulopalatoplasty one month after baseline polysomnography (PSG1) and a PSG2 6 months after surgery .

The control group perform PSG 1 and are then waiting 6 months, thereafter undergo PSG2, then surgery and PSG3 6 months after surgery. All patients are followed for four years with PSG. Patients fill in questionnaires at PSG sessions, and blood pressure control the morning after.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • AHI of 15 or more
  • Friedmans stage I+II
  • Tonsil size 0-1
  • BMI<34
  • ESS värde >7
  • Failed treatment with CPAP and mandibular device
Exclusion Criteria
  • Severe cardiovascular or neurological disease
  • ASA IV
  • Not interested in surgical treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Polysomnography: group differences in changes of apnea-hypopnea index (AHI)6 months

compare the two groups of changes in number of apneas and hypopneas per sleep hour measured with inlab polysomnography, between baseline and follow-up

Secondary Outcome Measures
NameTimeMethod
Questionnaire: group differences in changes of daytime sleepiness6 months

using validated questionnaire Epworth sleepiness scale measure changes between baseline and follow-up and compare the differences between groups

Questionnaire: group differences in changes of general health6 months

using validated question

Blood pressure: group differences in changes of blood pressure6 months

Trial Locations

Locations (1)

Orl dep, Karolinska University Hospital

🇸🇪

Stockholm, Sweden

Orl dep, Karolinska University Hospital
🇸🇪Stockholm, Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.